dear Kiruba,
What you might need to do is to get a second opinion. It is essential that you see a doctor who is expert in CML.
Given that your PH+ levels have not decreased from 84% over the last 2 years you really should have had an increased dose of imatinib/Glivec before now.
Even if there is no resistant mutation present, it might be that you are resistant to imatinib/Glivec for other reasons which are not currently well understood.
When did you start taking 800mg?
The higher dose of 800mg Glivec/imatinib might reduce your Ph+ levels.
If you do not see some sort of significant reduction in Ph+ levels within 2 months or so you should ask your doctor to organise a change in your therapy.
Currently the drugs that are available are:
dasatinib/Sprycel
OR
nilotinib/Tasigna.
BOTH these drugs are very effective in controling CML in patients who are resistant to imatinib/Glivec.
Many patients have vastly improved responses to these drugs and have cytogenetic responses with Ph+ levels reduced to much lower molecular levels.
So before you consider anything you should ask your doctor if he is willing to prescribe either dasatinib/Sprycel or nilotinib/Tasigna if you do not respond to 800mg imatinib/Glivec.
If he cannot do that for whatever reasons then you should ask to be transfered to another CML doctor.
SKI 606/bosutinib is a 3rd generation TKI and is in phase lll clinical trials. This drug is showing a lot of promise with an improved side effect profile.
However unless you can go to a centre that is involved in the clinical trials you will not easily get access to this drug.
Please let me know where you are currently being treated.
Best wishes,
Sandy
Sandy